Achieve life sciences to announce first quarter financial results and host conference call and webcast on may 12, 2022

Seattle and vancouver, british columbia, april 21, 2022 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will report its first quarter financial results and provide an update on the cytisinicline development program on thursday, may 12, 2022, at 4:30 pm edt. to access the webcast, please use the following link 1q22 earnings webcast . alternatively, you may access the live conference call by dialing (877) 472-9809 (u.s. & canada) or (629) 228-0791 (international) and referencing conference id 3887417. a webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
ACHV Ratings Summary
ACHV Quant Ranking